Swiss Basic Materials Stock News

SWX:BAER
SWX:BAERCapital Markets

Julius Bär Stock And Other European Safe Haven Financials In Focus

With investors questioning the reliability of US Treasuries and the dollar at the same time, attention is drifting toward markets that feel calmer and more predictable. That shift can create openings and risks in stocks linked to Swiss and other safe haven currencies, as clients reconsider where they hold their cash and portfolios. This article walks through three stocks exposed to that story and explains how the current backdrop could matter for each one. The sample of stocks covered below...
SWX:VZN
SWX:VZNCapital Markets

VZ Holding (SWX:VZN) Faces A 22% Above Fair Value Gap On Half Year Earnings

VZ Holding (SWX:VZN) is back in focus after reporting half year 2026 earnings on 14 August. Net income reached CHF 131.69 million, with basic earnings per share from continuing operations at CHF 3.34. See our latest analysis for VZ Holding. The earnings release appears to have supported momentum in VZ Holding’s share price, with a 30 day share price return of 8.68% and a 90 day share price return of 18.54%. Over a longer period, the 5 year total shareholder return of 120.71% contrasts with a...
SWX:TEMN
SWX:TEMNSoftware

Temenos (SWX:TEMN) Could Be 7% Undervalued As CHF 100 Million Buyback Starts

Temenos (SWX:TEMN) has announced a share repurchase program of up to CHF 100 million, authorized by its Board on 12 August 2026 and running until late February 2027, primarily for general corporate uses. See our latest analysis for Temenos. At a latest share price of CHF 74.40, Temenos has seen a 30 day share price return of 11.54% and a 1 year total shareholder return of 5.84%, while the 5 year total shareholder return remains down 43.41%. This suggests that recent momentum has improved from...
SWX:SDZ
SWX:SDZPharmaceuticals

Sandoz Group (SWX:SDZ) Looks Fully Valued After Henlius Biosimilar Deal

Sandoz Group (SWX:SDZ) is back in focus after the company agreed a collaboration with Shanghai Henlius Biotech to develop, manufacture and commercialise up to 10 biosimilars, with milestone payments up to US$322 million. See our latest analysis for Sandoz Group. The collaboration news arrives as Sandoz Group trades at CHF73.84, with a 30 day share price return of 15.45% and a year to date share price return of 29.05%. Over the past year, total shareholder return of 48.82% indicates that...
SWX:SENS
SWX:SENSElectronic

Sensirion Holding (SWX:SENS) Stock Grapples With FX Drag Despite Profit Jump

Sensirion Holding shares closed at CHF78.90 on Friday after a choppy week that left the stock slightly lower over seven days but modestly higher over the past month. The market reaction feels cautious. The headline from these H1 numbers is clear. Profitability in the sensor business is tightening under the microscope. Revenue for the first half came in at CHF179.0m while basic earnings per share reached CHF1.21. The key development is in the trailing picture. Net profit margin on the last...
SWX:ROP
SWX:ROPPharmaceuticals

Roche (SWX:ROP) Stock Looks Undervalued As US Manufacturing Expansion Continues

Roche Holding stock has delivered a 60.7% return over the past three years, and the recent run raises the question of whether the current price still lines up with what the valuation checks suggest. Over the past 3 years, Roche Holding has returned 60.7%, which puts recent gains front and centre in any assessment of what investors are now paying for the stock. Large ongoing investments in U.S. manufacturing capacity and diagnostics partnerships can support future cash generation. However,...
SWX:SIGN
SWX:SIGNPackaging

Is SIG Group’s (SWX:SIGN) CEO Shift Quietly Redefining Its Aseptic Systems Investment Story?

SIG Group AG recently appointed Ann-Kristin Erkens as CEO, replacing Mikko Keto, as its transformation programme delivered higher adjusted EBIT margins and stronger free cash flow, while the company reiterated its 2026 outlook and focus on aseptic system solutions. The planned Capital Markets Day in October, where SIG will outline its updated strategy and mid-term targets, gives investors a clearer lens on how the transformation programme could influence future business priorities and...
SWX:DKSH
SWX:DKSHTrade Distributors

Why DKSH Holding (SWX:DKSH) Is Back In The Spotlight

DKSH Holding (SWX:DKSH) is back in focus after its Malaysian unit reported a 34.8% year-on-year jump in second quarter net profit, supported by higher revenue and unrealised foreign exchange gains. See our latest analysis for DKSH Holding. At a share price of CHF66.40, DKSH Holding has seen its 30 day share price return of 3.75% and year to date share price return of 13.31%. The 1 year total shareholder return is 19.71%, which suggests momentum has been building rather than fading...
SWX:SIKA
SWX:SIKAChemicals

Sika (SWX:SIKA) Could Be 6% Undervalued Following Hybrid Bond Issue And Stable Outlook

Sika (SWX:SIKA) has drawn fresh investor attention after issuing €1b in hybrid capital bonds split into two callable, subordinated tranches, while S&P shifted its issuer rating outlook on the company from Negative to Stable. See our latest analysis for Sika. For investors, the hybrid bond issuance and S&P outlook revision arrive as Sika’s share price shows renewed momentum, with a 30-day share price return of 17.92% and a 90-day gain of 25.14%, even though the 5-year total shareholder return...
SWX:SCHN
SWX:SCHNMachinery

Schindler Holding (SWX:SCHN), What Is Behind The Fresh Attention?

Schindler Holding wins high profile New York modernization contract Schindler Holding (SWX:SCHN) has secured the modernization of 31 elevators at the General Motors Building in Midtown Manhattan, a high profile project that features its PORT destination system in a heavily trafficked office tower. See our latest analysis for Schindler Holding. The GM Building contract comes at a time when Schindler Holding’s share price has shown a 3.69% gain over the past month, while its year-to-date share...
SWX:GALE
SWX:GALEHealthcare

Should Galenica’s Softer 2026 Half-Year Profit but Reaffirmed Guidance Require Action From Galenica (SWX:GALE) Investors?

Galenica AG recently reported past half-year 2026 results, with sales rising to CHF 2,136.45 million and revenue to CHF 2,143.28 million, while net income decreased to CHF 66.35 million and earnings per share eased compared with the prior year period. Despite the softer profitability, management confirmed its 2026 outlook for consolidated net sales growth of 5.7% and EBIT growth between 6% and 8%, underscoring confidence in the business trajectory. With Galenica confirming its 2026 earnings...
SWX:SUNN
SWX:SUNNTelecom

Sunrise Communications (SWX:SUNN) Stock Faces Dividend Strain As Revenue Slips

Sunrise Communications stock came into today looking bruised, with the share price drifting down roughly 3% over the past month and about 3% over the last quarter. The long term pitch around a cheap telecom with a turnaround story met some hard numbers in the latest release. Revenue for the last twelve months sat at CHF 2.98b while the company still reported a loss from continuing operations and negative earnings per share. The real headline is not growth but pressure. Profitability remains...
SWX:DOCM
SWX:DOCMConsumer Retailing

DocMorris (SWX:DOCM) Stock Faces Loss Pressure As Revenue Expands

DocMorris stock closed at CHF10.00 on the day of its latest earnings, capping a volatile few months that included a sharp rebound over the past quarter. The market has been treating DocMorris as a high growth, online pharmacy bet. The headline from the latest numbers is more sobering. Revenue over the last twelve months reached about CHF1.1b, yet the company still reported a sizeable loss from continuing operations and a loss per share in the mid single digit CHF range. The expectation gap is...
SWX:STMN
SWX:STMNMedical Equipment

Straumann Holding (SWX:STMN) Stock Rich Valuation Meets Profit Margin Compression

Straumann Holding stock closed at CHF97.22 on the day its latest figures landed, well below an internal discounted cash flow estimate of CHF160.06. The market has been trimming exposure in recent weeks; yet the fresh numbers highlight a different story. Earnings sit on a compressed 13.7% net profit margin after a CHF136.0m one off loss in the last twelve months, while the P/E of 43.5x prices Straumann as a premium dental equipment play. The key question for you is whether that margin squeeze...
SWX:SIGN
SWX:SIGNPackaging

SIG Group (SWX:SIGN) Could Be 13% Below Fair Value Following CEO Shake Up

SIG Group (SWX:SIGN) abruptly replaced CEO Mikko Keto with former CFO Ann-Kristin Erkens less than six months into Keto’s tenure, raising questions about leadership stability despite reaffirmed guidance and an upcoming Capital Markets Day. See our latest analysis for SIG Group. For context, SIG Group’s 1 day share price return of 1.31% comes after a sharp 7 day share price decline of 14.20%. The 90 day share price return of 11.99% and year to date share price return of 14.92% contrast with a...
SWX:PMN
SWX:PMNElectrical

Phoenix Mecano (SWX:PMN) Stock Looks Cheap After Margin Led Profit Jump

Phoenix Mecano stock closed at CHF443 today, only slightly above where it was trading a month ago, even after investors digested fresh half year numbers. The headline from these results is not the modest revenue move. It is the sharp jump in operating profitability, with earnings before interest and tax up 23.5% on the back of stronger margins in the industrial units. Over a longer horizon the story shifts to valuation. The stock trades on a trailing P/E of 14x, while peers sit much higher...
SWX:SKAN
SWX:SKANLife Sciences

SKAN Group (SWX:SKAN) Stock Richly Valued As Margin Recovery Lags Backlog Growth

SKAN Group stock has been on a tear into this earnings print, closing at CHF62.70 and logging a roughly 32% gain over the past three months. That kind of run sets a high bar for a specialised pharma equipment supplier. The headline from H1 is clear. SKAN Group delivered a sharp reset in profitability with net profit of CHF5.4m and an EBITDA margin of 9.3% on CHF164.5m of net sales. Order intake of CHF247.6m and a CHF442m backlog reflect why the growth story still commands a premium P/E...
SWX:SDZ
SWX:SDZPharmaceuticals

Did Sandoz’s Expanded Henlius Biosimilar Pact Just Redraw Its (SWX:SDZ) Investment Narrative?

Sandoz Group AG recently announced a collaboration agreement with Shanghai Henlius Biotech, Inc. to develop, manufacture and commercialise up to 10 biosimilars, including proposed versions of cetuximab, evolocumab and belimumab, with Henlius handling development and manufacturing and Sandoz holding commercial rights outside China under a milestones-based deal of up to US$322 million. This partnership lifts Sandoz’s biosimilar pipeline from 39 assets with potential to reach up to 46,...
SWX:ALC
SWX:ALCMedical Equipment

Stronger Sales But Weaker Earnings Could Be A Game Changer For Alcon (SWX:ALC)

In the second quarter and first half of 2026, Alcon Inc. reported higher sales and revenue year on year, but net income for the six-month period fell to US$189 million from US$526 million, with basic and diluted earnings per share from continuing operations both dropping to US$0.39 from US$1.06. Even as Alcon maintained its full-year 2026 net sales growth guidance of 5% to 7%, the combination of rising revenue, lower profitability, and mixed valuation signals has sharpened investor focus on...
SWX:DOKA
SWX:DOKABuilding

3 Security Stocks Worth Watching As Demand For Better Protection Grows

Rising reports of violent homejackings around Lake Geneva are testing Switzerland’s image as a safe harbour for wealth, and that shift is drawing fresh attention to security and surveillance technology providers. When reputations and high end assets feel exposed, demand for better protection often moves quickly. This article walks through three stocks tied to these security themes and explains how the recent news could matter for their long term story. The stocks covered below are just a...
SWX:SCMN
SWX:SCMNTelecom

What Is Drawing Fresh Attention To Swisscom (SWX:SCMN)?

How Swisscom’s latest earnings update is shaping investor focus Swisscom (SWX:SCMN) drew fresh attention on 6 August 2026 after reporting half year results that combined lower sales of CHF 7,221 million with higher net income of CHF 669 million and basic EPS of CHF 12.92. See our latest analysis for Swisscom. Since the start of the year Swisscom’s share price has gained 10.36%, while the stock is down 5.47% over the past 90 days, and the 1 year total shareholder return of 14.85% points to...